Skip to main content
. 2022 Feb 1;9(2):206–220. doi: 10.1002/acn3.51510

Table 1.

Age and gender comparison of MS patients and HCs.

Parameters MS patients Healthy controls Statistical comparison
Number of subjects 22 18
Median age 34 34.5
Age range 22–55 26–55 Independent two sample t‐test; p = 0.7339
Gender ratio (male:female) 1:1.2 1:1 Chi square test, p = 0.7746

AHSCT, Autologous haematopoietic stem cell transplantation; ATG, Anti‐thymocyte globulin; BEAM, Carmustine, Etoposide, Cytarabine, Melphalan; cTfh, Circulating T follicular helper; DMT, Disease modifying therapies; HCs, Healthy controls; M, Months; MAIT, Mucosal‐associated invariant T; MS, Multiple Sclerosis; NK, Natural Killer; PD1, Programmed cell death protein 1; T‐conv, T‐conventional; Th17, T helper 17; Tregs, T regulatory cells; yr, Year.